Evidence map›Paper›PMID 41141962›Full record

ArticleMolecular therapy. Methods & clinical development2025

Landscape of

Aline Almeida-Oliveira, Martín Hernán Bonamino, Marisol Simões, Vitor Hugo Villaça Martins, Diana Praia Borges Freire, Adriana Danowski, Thais Pereira Catão, Julianna do Nascimento E Silva Varela, Mariana Torres Mazzi, Carla Lemos Gottgtroy and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular therapy. Methods & clinical development, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Aline Almeida-OliveiraCompetitive Intelligence Office (AICOM), Institute of Immunobiological Technology (Bio-Manguinhos), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-900, Brazil.
Martín Hernán BonaminoCell and Gene Therapy Program, Research Coordination, National Cancer Institute (INCA), Rio de Janeiro 20231-050, Brazil.
Marisol SimõesCompetitive Intelligence Office (AICOM), Institute of Immunobiological Technology (Bio-Manguinhos), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-900, Brazil.
Vitor Hugo Villaça MartinsCompetitive Intelligence Office (AICOM), Institute of Immunobiological Technology (Bio-Manguinhos), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-900, Brazil.
Diana Praia Borges FreireCompetitive Intelligence Office (AICOM), Institute of Immunobiological Technology (Bio-Manguinhos), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-900, Brazil.
Adriana DanowskiDepartment of Medical Affairs (DEAME), Clinical Studies and Post-Registration Surveillance, Institute of Immunobiological Technology (Bio-Manguinhos), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-900, Brazil.
Thais Pereira CatãoDepartment of Medical Affairs (DEAME), Clinical Studies and Post-Registration Surveillance, Institute of Immunobiological Technology (Bio-Manguinhos), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-900, Brazil.
Julianna do Nascimento E Silva VarelaDepartment of Medical Affairs (DEAME), Clinical Studies and Post-Registration Surveillance, Institute of Immunobiological Technology (Bio-Manguinhos), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-900, Brazil.
Mariana Torres MazziDepartment of Medical Affairs (DEAME), Clinical Studies and Post-Registration Surveillance, Institute of Immunobiological Technology (Bio-Manguinhos), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-900, Brazil.
Carla Lemos GottgtroyDepartment of Medical Affairs (DEAME), Clinical Studies and Post-Registration Surveillance, Institute of Immunobiological Technology (Bio-Manguinhos), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-900, Brazil.
Amanda de Miranda MarquesDepartment of Medical Affairs (DEAME), Clinical Studies and Post-Registration Surveillance, Institute of Immunobiological Technology (Bio-Manguinhos), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-900, Brazil.
Monique Menegaci BarbosaCompetitive Intelligence Office (AICOM), Institute of Immunobiological Technology (Bio-Manguinhos), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-900, Brazil.
Beatriz de Castro FialhoCompetitive Intelligence Office (AICOM), Institute of Immunobiological Technology (Bio-Manguinhos), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-900, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autoimmune diseaseschimeric antigen receptor, CARCRISPRex vivo gene therapylentivirusneoplastic diseasesnon-viral vectorsstrategic foresightviral vectors

Identifiers

PMID41141962
PMCPMC12547725

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.